Global cancer statistics
By A. Jemal, F. Bray, Melissa M. Center, J. Ferlay, Elizabeth E. Ward, David Forman. Ca, 2011
65,229 citations recorded by the source corpus.
The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer‐causing behaviors, particularly smoking, in economically developing countries. Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the deaths occurred in the economically developing world. Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females, accounting for 23% of the total cancer cases and 14% of the cancer deaths. Lung cancer is the leading cancer site in males, comprising 17% of the total new cancer cases and 23% of the total cancer deaths. Breast cancer is now also the leading cause of cancer death among females in economically developing countries, a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Further, the mortality burden for lung cancer among females in developing countries is as high as the burden for cervical cancer, with each accounting for 11% of the total female cancer deaths. Although overall cancer incidence rates in the developing world are half those seen in the developed world in both sexes, the overall cancer mortality rates are generally similar. Cancer survival tends to be poorer in developing countries, most likely because of a combination of a late stage at diagnosis and limited access to timely and standard treatment. A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination (for liver and cervical cancers), and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake. Clinicians, public health professionals, and policy makers can play an active role in accelerating the application of such interventions globally. CA Cancer J Clin 2011. © 2011 American Cancer Society, Inc.
Subfields: Epidemiology, Oncology
View Paper: https://www.semanticscholar.org/paper/25793259a06ee170f5fd3204a23d01173467d745
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Joel T. Dudley
- Julien Sage
- S. Tamil Selvi
- M. Karin
- S. Kjaer
- Atul J. Butte
- N. Albert Singh
- Christopher R'e
In Oncology
Citations in the corpus
- Lung cancer: epidemiology, etiology, and prevention. (2011, background): “The authors concluded, (1) the excessive and prolonged use of tobacco was an important factor in the induction of lung cancer; (2) lung cancer in a nonsmoker was rare (however, this is currently not the case [discussed later in section on never smokers]); and (3) there could be a lag period of 10 ye”
- Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018, background): “Non-small cell lung cancer (NSCLC) accounts for 80%–90% of lung cancers, while small cell lung cancer (SCLC) has been decreasing in frequency in many countries over the past two decades [4].”